News
GSK's novel antibiotic gepotidacin matches current therapy in gonorrhoea, raising hope of new oral therapy as cases of the infection rise worldwide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback